Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Equity Ratio (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Equity Ratio data on record, last reported at 0.77 in Q3 2025.

  • For Q3 2025, Equity Ratio rose 38.37% year-over-year to 0.77; the TTM value through Sep 2025 reached 0.77, up 38.37%, while the annual FY2024 figure was 0.38, 113.2% up from the prior year.
  • Equity Ratio reached 0.77 in Q3 2025 per COEP's latest filing, up from 0.58 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.77 in Q3 2025 and bottomed at 0.29 in Q1 2024.
  • Average Equity Ratio over 5 years is 0.23, with a median of 0.2 recorded in 2022.
  • Peak YoY movement for Equity Ratio: crashed 305.63% in 2024, then soared 886.37% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.35 in 2021, then soared by 61.93% to 0.56 in 2022, then crashed by 68.35% to 0.18 in 2023, then surged by 113.2% to 0.38 in 2024, then surged by 102.76% to 0.77 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.77 in Q3 2025, 0.58 in Q2 2025, and 0.55 in Q1 2025.